XOMA Corp Business Operations Contracts & Agreements
21 Contracts & Agreements
- Collaboration Agreements (8 contracts)
- Development Agreements (3)
- Indemnification Agreements (4)
- Management Agreements (1)
- Sales Agreements (3)
- Settlement Agreements (2)
- At Market Issuance Sales Agreement, dated August 5, 2021, by and between XOMA Corporation and B. Riley Securities, Inc (Filed With SEC on August 5, 2021)
- Settlement and Release Agreement, dated April 15, 2021, by and among XOMA (US) LLC and Affimed N.V., Affimed GmbH Affimed (Filed With SEC on August 5, 2021)
- Form of Amended and Restated Indemnification Agreement for Directors and Officers (Filed With SEC on March 10, 2021)
- Collaboration and License Agreement, dated as of March 5, 2020, by and between XOMA (US) LLC and Cadila Healthcare Limited (Filed With SEC on May 5, 2020)
- SETTLEMENT AND AMENDED LICENSE AGREEMENT (Filed With SEC on March 9, 2016)
- Amendment No. 1, effective November 4, 2014, to the Amended and Restated Collaboration and License Agreement, effective February 14, 2012, by and among XOMA (US) LLC (assigned... (Filed With SEC on March 11, 2015)
- Amendment No. 2, effective January 9, 2015, to the Amended and Restated Collaboration and License Agreement, effective February 14, 2012, by and among XOMA (US) LLC, Les... (Filed With SEC on March 11, 2015)
- Foreign Exchange and Options Master Agreement (FEOMA) dated as of May 16, 2011 between Royal Bank of Canada and XOMA Ltd., with letter agreement dated May 17, 2011 (Filed With SEC on August 4, 2011)
- At Market Issuance Sales Agreement (Filed With SEC on October 26, 2010)
- DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on March 11, 2010)
- At Market Issuance Sales Agreement (Filed With SEC on November 9, 2009)
- [*] indicates that a confidentialportion of the text of this agreement has been omitted. DISCOVERY COLLABORATION AGREEMENT (Filed With SEC on November 9, 2009)
- SECOND AMENDMENT TO COLLABORATION AGREEMENT (Filed With SEC on March 11, 2009)
- AMENDED AND RESTATED RESEARCH, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (Filed With SEC on March 11, 2009)
- AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (Filed With SEC on March 8, 2007)
- AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (Filed With SEC on March 8, 2007)
- AMENDED AND RESTATED INDEMNIFICATION AGREEMENT (Filed With SEC on March 8, 2007)
- COLLABORATION AGREEMENT (Filed With SEC on August 9, 2006)
- RESEARCH, DEVELOPMENT ANDCOMMERCIALIZATION AGREEMENT dated as of May 26, 2005 (Filed With SEC on August 8, 2005)
- SECOND AMENDED AND RESTATED COLLABORATION AGREEMENT (Filed With SEC on March 15, 2005)
- Amendment to Amended and Restated Research, Development and Commercialization Agreement, between the Company and Novartis Vaccine and Diagnostics, Inc., dated September 30, 2015... (Filed With SEC on November 5, 2020)
